GregoryPPriebeMD
Pediatric Infectious Disease • Boston, MADirector of Research, Division of Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital; Associate Member, Broad Institute of MIT and Harvard; Associate Professor, Harvard Medical School
Dr. Priebe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Div. Critical Care Med. Children's Hosp. Boston Bader 6
Boston, MA 02115Phone+1 617-355-7327
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 1997 - 2001- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1993 - 1997
Harvard Medical SchoolClass of 1993
Certifications & Licensure
MA State Medical License 1996 - 2025- American Board of Pediatrics Pediatric Critical Care Medicine
- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections Start of enrollment: 2014 Nov 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Plasma Microbial Cell-Free DNA Metagenomic Next-Generation Sequencing in People With Cystic Fibrosis.Mollie G Wasserman, Jonathan Greenberg, Brandon Hall, Steven J Staffa, Gregory S Sawicki
Pediatric Pulmonology. 2024-11-06 - Risk factors for central line-associated bloodstream infection in the pediatric intensive care setting despite standard prevention measures.Kaitlyn T Marks, Katherine D Rosengard, Jennifer D Franks, Steven J Staffa, Jenny Chan Yuen
Infection Control and Hospital Epidemiology. 2024-10-10 - 1 citationsmutations mediate phenotypic switching in an opportunistic human lung pathogen.Alexandra J Poret, Matthew Schaefers, Christina Merakou, Kathryn E Mansour, Georgia K Lagoudas
Biorxiv. 2024-02-06
Grant Support
- Vaccines for Pseudomonas aeruginosaDepartment of Defense2019–2023
- Th17-inducing vaccines for Pseudomonas aeruginosa in cystic fibrosisCystic Fibrosis Foundation2017–2019
- Targeting Burkholderia FixL as a novel antimicrobial strategy in CFCystic Fibrosis Foundation2013–2015
- Mechanisms Of Adaptive Immunity To P. Aeruginosa In The LungNational Heart, Lung, And Blood Institute2009–2012
- Adaptive Immunity Of P. Aeruginosa In Cystic FibrosisNational Heart, Lung, And Blood Institute2005–2006
- Cellular Immunity To P. Aeruginosa Candidate VaccinesNational Institute Of Allergy And Infectious Diseases2001–2005
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
